Albia, Jose P.
HRN: 22-95-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/25/2023
05/02/2023
IV
500mg
Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes